INGN
Inogen, Inc. NASDAQ Listed Feb 14, 2014$6.43
After hrs
$6.43
+0.00%
Mkt Cap $174.1M
52w Low $5.34
28.8% of range
52w High $9.13
50d MA $6.62
200d MA $6.94
P/E (TTM)
—
EV/EBITDA
—
P/B
0.9x
Debt/Equity
0.1x
ROE
-11.8%
P/FCF
-8.1x
RSI (14)
48.30
ATR (14)
$0.28
Beta
1.71
50d MA
$6.62
200d MA
$6.94
Avg Volume
388.1K
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
301 Coromar Drive · Goleta, CA 93117 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | AMC | -0.24 | -0.30 | -25.0% | 7.19 | -0.3% | -2.4% | -5.7% | +0.9% | +1.9% | -0.1% | — |
| Feb 24, 2026 | AMC | -0.36 | -0.26 | +27.8% | 5.84 | -6.3% | +2.9% | +7.2% | -5.3% | +1.3% | +0.5% | — |
| Nov 5, 2025 | AMC | -0.22 | -0.20 | +9.1% | 7.39 | -0.8% | -4.9% | -0.6% | +0.4% | -0.4% | +1.4% | — |
| Aug 7, 2025 | AMC | -0.22 | -0.15 | +31.8% | 5.87 | +2.2% | +10.4% | +8.6% | +7.7% | +1.6% | -0.4% | — |
| May 7, 2025 | AMC | -0.52 | -0.25 | +51.9% | 7.17 | +0.7% | -11.4% | -1.7% | +1.0% | -2.5% | -4.2% | — |
| Feb 25, 2025 | AMC | -0.56 | -0.41 | +26.8% | 9.52 | +25.4% | -14.8% | -2.0% | +4.8% | -2.4% | -1.2% | — |
| Nov 7, 2024 | AMC | -0.49 | -0.25 | +49.0% | 9.46 | +13.6% | +17.2% | -0.6% | -5.3% | -1.1% | -3.7% | — |
| Aug 6, 2024 | AMC | -0.55 | -0.24 | +56.4% | 8.15 | +21.5% | +36.0% | +5.3% | +5.6% | -4.3% | +5.9% | — |
| May 7, 2024 | AMC | -0.76 | -0.62 | +18.4% | 7.30 | +12.3% | +12.9% | +5.5% | -2.6% | +4.3% | +1.1% | — |
| Feb 27, 2024 | AMC | -0.62 | -1.14 | -83.9% | 9.34 | -24.0% | -32.7% | +5.7% | +5.7% | -5.0% | +1.0% | — |
| Nov 7, 2023 | AMC | -0.57 | -1.97 | -245.6% | 5.27 | -5.9% | -1.1% | -7.7% | +0.8% | +0.2% | +13.0% | — |
| Aug 7, 2023 | AMC | -0.59 | -0.42 | +28.8% | 7.50 | -19.7% | -13.6% | -4.0% | -1.8% | +1.0% | -0.3% | — |
| May 4, 2023 | AMC | -0.77 | -0.63 | +18.2% | 13.75 | +0.4% | -5.4% | -8.9% | -5.7% | -0.7% | -0.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 22 | Needham | Upgrade | Hold → Buy | — | $5.96 | $6.54 | +9.7% | +13.3% | -3.3% | +1.4% | -1.4% | +0.0% |
| May 8 | Stifel | Maintains | Hold → Hold | — | $7.17 | $7.22 | +0.7% | -11.4% | -1.7% | +1.0% | -2.5% | -4.2% |
| Apr 9 | Needham | Maintains | Hold → Hold | — | $6.59 | $6.48 | -1.7% | +6.8% | +0.6% | +3.2% | +0.1% | -1.6% |
| Feb 27 | Needham | Maintains | Hold → Hold | — | $8.11 | $8.02 | -1.1% | -2.0% | +4.8% | -2.4% | -1.2% | +3.0% |
| Feb 26 | Needham | Maintains | Hold → Hold | — | $9.52 | $11.94 | +25.4% | -14.8% | -2.0% | +4.8% | -2.4% | -1.2% |
| Jan 30 | Needham | Maintains | Hold → Hold | — | $12.53 | $12.72 | +1.5% | -4.6% | -2.2% | -1.9% | +4.3% | -0.9% |
| Jan 14 | Needham | Maintains | Hold → Hold | — | $10.33 | $11.44 | +10.7% | +2.8% | +2.4% | -3.3% | -0.5% | +6.9% |
| May 8 | Stifel | Maintains | Hold → Hold | — | $7.30 | $8.20 | +12.3% | +12.9% | +5.5% | -2.6% | +4.3% | +1.1% |
| Feb 15 | William Blair | Upgrade | Market Perform → Outperform | — | $8.51 | $9.16 | +7.6% | +19.3% | -1.2% | -5.4% | -1.1% | -0.2% |
| Nov 8 | JP Morgan | Maintains | Underweight → Underweight | — | $5.27 | $4.96 | -5.9% | -1.1% | -7.7% | +0.8% | +0.2% | +13.0% |
| Aug 8 | Stifel | Maintains | Hold → Hold | — | $7.50 | $6.02 | -19.7% | -13.6% | -4.0% | -1.8% | +1.0% | -0.3% |
| Aug 8 | JP Morgan | Downgrade | Neutral → Underweight | — | $7.50 | $6.02 | -19.7% | -13.6% | -4.0% | -1.8% | +1.0% | -0.3% |
| Jul 14 | Needham | Downgrade | Buy → Hold | — | $10.26 | $9.62 | -6.2% | -13.4% | +2.5% | -4.9% | -3.0% | +2.9% |
| Apr 20 | Needham | Maintains | Buy → Buy | — | $13.00 | $12.97 | -0.2% | +2.2% | +0.8% | +2.5% | -3.9% | -1.3% |
| Feb 28 | Needham | Maintains | Buy → Buy | — | $16.50 | $16.20 | -1.8% | -5.0% | -0.7% | +1.0% | -1.5% | -4.3% |
| Feb 24 | Needham | Maintains | Buy → Buy | — | $23.16 | $20.35 | -12.1% | -31.4% | +3.8% | -5.0% | -0.7% | +1.0% |
| Jan 17 | William Blair | Downgrade | Outperform → Market Perform | — | $23.28 | $22.45 | -3.6% | -2.9% | -2.7% | -1.3% | +4.1% | +6.5% |
| Nov 3 | JP Morgan | Maintains | Neutral → Neutral | — | $21.36 | $20.87 | -2.3% | -5.1% | +2.0% | +0.8% | -0.3% | -2.9% |
| Nov 2 | Needham | Maintains | Buy → Buy | — | $23.18 | $21.96 | -5.3% | -7.9% | -5.1% | +2.0% | +0.8% | -0.3% |
| May 9 | Stifel | Maintains | Hold → Hold | — | $24.94 | $24.22 | -2.9% | -5.6% | -0.2% | -2.6% | +5.8% | +4.5% |
| May 6 | Needham | Maintains | Buy → Buy | — | $24.09 | $24.11 | +0.1% | +3.5% | -5.6% | -0.2% | -2.6% | +5.8% |
| Dec 9 | Needham | Upgrade | Hold → Buy | — | $33.08 | $34.63 | +4.7% | +4.4% | -0.2% | -3.5% | -2.1% | +1.4% |
| Nov 8 | Stifel | Maintains | Hold → Hold | — | $36.92 | $37.07 | +0.4% | +1.4% | -2.7% | -0.1% | -4.3% | -2.6% |
| Nov 5 | SVB Leerink | Maintains | Market Perform → Market Perform | — | $38.88 | $40.49 | +4.1% | -5.0% | +1.4% | -2.7% | -0.1% | -4.3% |
| Nov 2 | JP Morgan | Upgrade | Underweight → Neutral | — | $39.66 | $40.03 | +0.9% | -3.2% | +2.3% | -1.0% | -5.0% | +1.4% |
| Aug 5 | KeyBanc Capital Markets | Downgrade | Overweight → Sector Weight | — | $82.26 | $65.39 | -20.5% | -26.7% | +6.6% | +1.2% | -0.7% | -3.1% |
| Jun 4 | William Blair | Upgrade | Market Perform → Outperform | — | $59.49 | $62.25 | +4.6% | +7.1% | -1.5% | +0.8% | -1.4% | +0.1% |
| May 5 | SVB Leerink | Maintains | Market Perform → Market Perform | — | $67.09 | $69.00 | +2.8% | -1.9% | +0.3% | +0.9% | -1.9% | +2.2% |
| May 5 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $67.09 | $69.00 | +2.8% | -1.9% | +0.3% | +0.9% | -1.9% | +2.2% |
| Feb 25 | SVB Leerink | Maintains | Market Perform → Market Perform | — | $51.59 | $53.91 | +4.5% | +2.3% | -0.5% | +1.2% | -6.9% | -2.3% |
| Dec 14 | KeyBanc | Upgrade | Sector Weight → Overweight | — | $38.46 | $42.76 | +11.2% | +7.5% | -0.6% | -0.3% | +0.3% | -0.7% |
| Dec 14 | KeyBanc Capital Markets | Upgrade | Sector Weight → Overweight | — | $38.46 | $42.76 | +11.2% | +7.5% | -0.6% | -0.3% | +0.3% | -0.7% |
| Aug 5 | SVB Leerink | Maintains | Market Perform → Market Perform | — | $30.64 | $31.98 | +4.4% | +13.3% | -1.4% | +1.9% | -7.0% | -1.4% |
| Jul 23 | Needham | Downgrade | Buy → Hold | — | $34.97 | $33.34 | -4.7% | -5.7% | -3.2% | -2.9% | -3.3% | +4.4% |
| Jun 11 | William Blair | Downgrade | Outperform → Market Perform | — | $37.39 | $35.50 | -5.1% | -10.9% | -1.4% | +4.7% | -0.9% | -0.1% |
| Jun 1 | SVB Leerink | Maintains | Market Perform → Market Perform | — | $38.00 | $37.24 | -2.0% | +1.4% | +0.8% | -1.2% | -0.7% | +8.2% |
| May 6 | Needham | Maintains | Buy → Buy | — | $52.90 | $48.58 | -8.2% | -25.3% | +4.3% | -2.6% | -1.3% | -6.6% |
| May 6 | SVB Leerink | Maintains | Market Perform → Market Perform | — | $52.90 | $48.58 | -8.2% | -25.3% | +4.3% | -2.6% | -1.3% | -6.6% |
| Feb 26 | JP Morgan | Maintains | Underweight → Underweight | — | $41.98 | $37.25 | -11.3% | +14.1% | +0.1% | -4.5% | +4.1% | -7.5% |
| Dec 20 | JP Morgan | Maintains | Underweight → Underweight | — | $71.07 | $71.52 | +0.6% | -0.1% | -0.1% | +0.8% | -1.6% | -2.5% |
| Nov 6 | Needham | Upgrade | Hold → Buy | — | $59.32 | $68.63 | +15.7% | +14.1% | +2.0% | +0.0% | -2.1% | +2.1% |
| Aug 8 | SVB Leerink | Downgrade | Outperform → Market Perform | — | $42.32 | $41.98 | -0.8% | +10.3% | -3.7% | +0.1% | +2.2% | -6.6% |
| Aug 8 | Stifel | Downgrade | Buy → Hold | — | $42.32 | $41.98 | -0.8% | +10.3% | -3.7% | +0.1% | +2.2% | -6.6% |
| Jul 3 | JP Morgan | Downgrade | Neutral → Underweight | — | $65.26 | $63.46 | -2.8% | +0.2% | +0.8% | -3.3% | -0.7% | +0.7% |
| Jun 28 | Needham | Downgrade | Strong Buy → Buy | — | $65.49 | $63.53 | -3.0% | +1.9% | -0.1% | -2.2% | +0.2% | +0.8% |
| May 8 | JP Morgan | Downgrade | Overweight → Neutral | — | $91.14 | $64.62 | -29.1% | -25.6% | +6.6% | +2.5% | -1.2% | +0.3% |
| May 8 | Stifel | Maintains | Buy → Buy | — | $91.14 | $64.62 | -29.1% | -25.6% | +6.6% | +2.5% | -1.2% | +0.3% |
| Nov 20 | Needham | Upgrade | Buy → Strong Buy | — | $137.45 | $138.43 | +0.7% | +3.0% | -2.5% | +0.5% | +2.2% | +0.3% |
| Sep 10 | Needham | Downgrade | Strong Buy → Buy | — | $263.85 | $262.40 | -0.5% | +1.5% | +2.1% | +0.6% | +1.2% | +1.7% |
| Jun 6 | KeyBanc | Maintains | Sector Weight → Equal Weight | — | $191.88 | $190.58 | -0.7% | -0.2% | -5.2% | -0.1% | +0.1% | +1.1% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 29, 2026 | Yi Boyer Jennifer M | EVP Entrprs Enblmnt, Ch HR Off | Sell | 10,770 | $6.53 | $70K | 15,977 | -1.81% | +4.79% |
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
Vafa Jamali's appointment as director signals potential strategic shifts in governance and decision-making, warranting investor attention to board composition changes affecting corporate direction and oversight quality.
Apr 6
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
A new executive at Baxter or Inogen with a $525,000 base salary and 70% bonus potential signals leadership continuity, but investors should monitor whether this hire strengthens operational execution or represents reactive replacement.
Mar 30
8-K · 7.01
! Medium
Inogen Inc -- 8-K 7.01: Regulation FD Disclosure
Inogen's board authorized a $30 million share repurchase program, signaling management confidence in the company's valuation and demonstrating commitment to returning capital to shareholders.
Feb 24
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | 1,116,736 | $8M | Reduced | Dec 2025 |
| 2 | Acadian Asset Management Llc | 1,083,483 | $7M | — | Mar 2026 |
| 3 | Vanguard Capital Management Llc | 1,036,705 | $6M | New | Mar 2026 |
| 4 | Eversource Wealth Advisors, Llc | 47,751 | $6M | Added | Mar 2026 |
| 5 | Point72 Asset Management | 642,366 | $4M | Added | Mar 2026 |
| 6 | Arrowstreet Capital, Limited Partnership | 586,159 | $4M | Added | Mar 2026 |
| 7 | Renaissance Technologies Llc | 478,800 | $3M | Reduced | Mar 2026 |
| 8 | Aqr Capital Management Llc | 427,118 | $3M | Added | Mar 2026 |
| 9 | Jpmorgan Chase & Co | 427,656 | $3M | Reduced | Mar 2026 |
| 10 | Prudential Financial Inc | 369,070 | $2M | Reduced | Mar 2026 |
| 11 | Nuveen, Llc | 363,682 | $2M | Reduced | Mar 2026 |
| 12 | Peapod Lane Capital Llc | 258,645 | $2M | New | Mar 2026 |
| 13 | Qube Research & Technologies Ltd | 242,157 | $1M | Reduced | Mar 2026 |
| 14 | Vanguard Portfolio Management Llc | 225,566 | $1M | New | Mar 2026 |
| 15 | Monaco Asset Management Sam | 198,242 | $1M | Added | Dec 2025 |
| 16 | Tudor Investment Corp | 197,729 | $1M | New | Mar 2026 |
| 17 | Ubs Group Ag | 184,509 | $1M | Added | Mar 2026 |
| 18 | Northern Trust Corp | 183,288 | $1M | Added | Mar 2026 |
| 19 | Citadel Advisors Llc | 176,689 | $1M | Reduced | Mar 2026 |
| 20 | Connor, Clark & Lunn Investment Management Ltd. | 129,864 | $873K | Reduced | Dec 2025 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$174.1M
Enterprise Value
$54.6M
P/E (TTM)
—
Forward P/E
—
PEG Ratio
0.18x
P/B
0.91x
P/S
0.50x
P/FCF
-8.07x
EV/EBITDA
—
Shares Out
27.2M
Financials (TTM)
Revenue
$351.5M
Net Income
-$24.9M
EBITDA
-$5.2M
Free Cash Flow
-$21.6M
Op Cash Flow
-$11.2M
EPS Basic
$-0.85
EPS Diluted
$-0.91
EPS Forward
$-0.78
Gross Margin
48.7%
Op Margin
-8.8%
Net Margin
-7.1%
Balance Sheet
Total Assets
$298.6M
Total Liab.
$106.4M
Total Equity
$192.2M
Cash
$119.6M
LT Debt
$0
Book Value/Sh
$7.07
Debt/Equity
0.09x
Current Ratio
3.12
Quick Ratio
2.71
Returns & Growth
ROE
-11.8%
ROA
-7.6%
ROIC
-12.3%
Rev Growth YoY
+3.9%
EPS Growth YoY
+44.1%
Price Returns
2W
-4.6%
1M
-8.7%
3M
+6.4%
6M
-8.3%
12M
+0.9%
Technicals
52W High
$9.13
52W Low
$5.34
50d MA
$6.62
200d MA
$6.94
RSI (14)
48.30
ATR (14)
$0.28
Beta
1.71
Avg Volume
388K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$26.00
High
$26.00
Low
$26.00
Median
$26.00
Data updated apr 25, 2026 3:36pm
· Source: financialmodelingprep.com